Arcutis Biotherapeutics, Inc. ARQT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s short-term investments?
- Arcutis Biotherapeutics, Inc. (ARQT) reported short-term investments of $189.24M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s short-term investments changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s short-term investments increased by 30.5% year-over-year, from $144.98M to $189.24M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s short-term investments has grown at a -4.1% compound annual growth rate (CAGR), from $219.36M to $178.08M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.